News Fable 30 Aug 2026, 22:452 min read

Fable's expected playtime and what it means for gamers

Fable's expected playtime and what it means for gamers

Intelligence Summary

  • Discover Fable's expected playtime and what it means for gamers, with an analysis of Playground Games' new RPG.

In short

  • Fable's main quest is expected to take around 20 hours.
  • In addition to the main quest, there will be 15-20 hours of side quests and open-world exploration.
  • By comparison, the original Fable's main quest took 12.5 hours.

Analysis by GAME-scanner

The new Fable, developed by Playground Games, promises a substantial RPG experience with an estimated 20-hour main quest. That marks a significant expansion compared with the original Fable from 2004, which offered just 12.5 hours of main story content. This increase in playtime may appeal to gamers looking for a deeper and more engaging experience. The addition of 15-20 hours of side quests and open-world content gives players the chance to explore the world of Fable more thoroughly, which could significantly boost the game's replay value. However, it is important to consider how these estimated playtimes line up with player expectations. The final game may end up containing more or less content than is currently estimated, which could affect overall player satisfaction.

What does this mean for players?

For gamers, the expected playtime means they can prepare for a more expansive experience. The chance to play through both the main quest and a substantial amount of side content could increase the game's replay value. That may be especially appealing to players who enjoy exploration and creating their own adventures. On the other hand, some players may prefer shorter, more focused experiences, which could lead to mixed reactions to the length of the main story.

Timeline

  • 2026-08-30: Fable's delay to 2027 announced.

  • 2027-02-23: Expected release date for Fable.

Related GAME-scanner articles

Sources

Video

Media

Tags

More gaming news

All news

Comments

0 comments